Real-life CPI +/- ASP-based chemo for NK/T NHL: ORR 46%, 2-y PFS 22.4%, and OS51%. #LYSA onlinelibrary.wiley.com/doi/full/10....

Efficacy of anti‐PD1 therapy i...